Corbus Pharmaceuticals's market cap is currently $100.85M. The company's EPS TTM is $-4.695; its P/E ratio is ―; Corbus Pharmaceuticals is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-1.26. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 881.71K	$ 3.94M	$ 36.14M
Gross Profit	$ -31.17M	$ -1.49M	$ -757.53K	$ 3.84M	$ 36.05M
Operating Income	$ -45.08M	$ -39.84M	$ -55.99M	$ -122.81M	$ -77.10M
EBITDA	$ -44.44M	$ -38.73M	$ -54.97M	$ -121.69M	$ -76.37M
Net Income	$ -44.60M	$ -55.83M	$ -45.55M	$ -111.30M	$ -69.15M
Balance Sheet
Cash & Short-Term Investments	$ 20.91M	$ 59.20M	$ 97.65M	$ 85.43M	$ 31.75M
Total Assets	$ 28.27M	$ 66.31M	$ 107.73M	$ 102.29M	$ 49.14M
Total Debt	$ 20.88M	$ 25.09M	$ 26.59M	$ 26.84M	$ 9.45M
Net Debt	$ 7.16M	$ 8.09M	$ 1.58M	$ -58.60M	$ -22.30M
Total Liabilities	$ 35.18M	$ 33.32M	$ 38.62M	$ 57.02M	$ 42.98M
Stockholders' Equity	$ -6.90M	$ 32.99M	$ 69.11M	$ 45.27M	$ 6.16M
Cash Flow
Free Cash Flow	$ -36.10M	$ -37.56M	$ -48.24M	$ -100.17M	$ -48.46M
Operating Cash Flow	$ -36.10M	$ -37.54M	$ -48.18M	$ -99.69M	$ -45.72M
Investing Cash Flow	$ 35.64M	$ 30.07M	$ -73.42M	$ -484.49K	$ -2.74M
Financing Cash Flow	$ -2.82M	$ -533.62K	$ 60.82M	$ 154.87M	$ 38.46M

Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History

Income Statement >

Corbus Pharmaceuticals Debt to Assets

Balance Sheet >

Corbus Pharmaceuticals Cash Flow

Cash Flow >

Corbus Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing